Diabetes Drugs
Product Name
Tagrisso is a prescription medication used to treat specific types of non-small cell lung cancer (NSCLC) that carry mutations in the EGFR gene.
Please note: a valid prescription is required for all prescription medication.
Tagrisso is a third-generation tyrosine kinase inhibitor designed to target epidermal growth factor receptor (EGFR) mutations, helping control the growth of cancer cells in NSCLC. This advanced therapy offers proven benefits, including longer progression-free survival and improved overall outcomes compared to earlier EGFR inhibitors.
Tagrisso is available in dose options designed to match your treatment plan and your doctor’s prescription:
Tagrisso 40 mg, 30 tablets.
Tagrisso 80 mg, 30 tablets.
No reviews yet.
No shipping information available.
No rewards information available.
No doctor visit information available.
Candesartan HCTZ is a prescription medicine that combines candesartan cilexetil, an angiotensin II receptor blocker (ARB), with hydrochlorothiazide, a thiazi...
Lucentis Vial is a prescription injectable medicine used to treat several serious eye diseases that can lead to vision loss. It contains ranibizumab, which h...
Vermazol is an antiparasitic medication used to treat a variety of intestinal worm infections.
Diabetes Drugs
Product Name
Your cart is empty